Pharmapoint: Parkinsons Disease Industry 2015,Share and Size, Trends and Price, Forecast and Market Analysis to 2022

Hexa Reports

Market Research Reports and Insightful Company Profiles

PharmaPoint: Parkinsons Disease Industry 2015,Share and

Size,Trends and Price,Forecast and Market Analysis to 2022

Summary

GlobalData has released its pharma report, "PharmaPoint: Parkinson's Disease - Current and Future

Players". The report is a vital source of up-to-date information with in-depth analysis on the companies

in the rapidly growing Parkinson's Disease Market. The report identifies and analyses the key companies

shaping and driving the global Parkinson's Disease market. The report provides insight into the

competitive Parkinson's Disease landscape, including new companies entering the market. This report is

built using data and information sourced from proprietary databases, primary and secondary and inhouse analysis by GlobalData's team of industry experts.

Browse Detail Report With TOC @ http://www.hexareports.com/report/pharmapoint-parkinson-sdisease-current-and-future-players/details

Lidoderm, the topical analgesic 5% lidocaine patch (medicated plaster), was invented by US pharmacist

Harry Hind (Hind Healthcare) and was approved by the FDA in March 1999 for the treatment of PHN.

Teikoku Seiyaku then assumed from Hind full responsibility for manufacture of the Lidoderm patch,

while Endo Pharmaceuticals has the rights to market the patch in the US. The patch was launched by

Endo in the US in September 1999 for the treatment of PHN. In Europe, the patch was co-developed by

Teikoku and the German drug company, Grunenthal, and was launched in the EU in 2007 under the

brand name Versatis.

Hexa Reports

Market Research Reports and Insightful Company Profiles

Scope









Investigation of current and future market competition for Parkinson's Disease

Competitor assessment

Coverage of key market players and company profiles including business description, financial

overview and SWOT analysis.

Strategic assessment of Parkinson's Disease sector through market impact analysis, future...